- In April 2024, Labcorp announced the expansion of its precision diagnostics offerings through the launch of a new multi-omics platform designed to integrate genomic, proteomic, and metabolomic data. This innovation aims to enhance early disease detection and personalized treatment strategies, reinforcing Labcorp’s leadership in advanced diagnostic services across North America. The initiative highlights the growing shift towards holistic, data-driven healthcare solutions within clinical laboratories
- In March 2024, Quest Diagnostics partnered with PathAI, a digital pathology company, to integrate artificial intelligence into pathology workflows, accelerating diagnostic accuracy and turnaround times. This collaboration emphasizes the increasing role of AI in transforming diagnostic operations and supports efforts to improve cancer detection and reporting efficiency across U.S. labs
- In February 2024, Mayo Clinic Laboratories unveiled a new AI-powered decision support tool integrated into its laboratory information system (LIS), designed to assist clinicians in test selection and interpretation. This tool improves diagnostic precision and supports value-based care initiatives, highlighting Mayo’s continued innovation in clinical diagnostics
- In January 2024, Sonic Healthcare USA acquired Medical Laboratory Associates, a regional independent laboratory in the Mid-Atlantic, to expand its service network and improve accessibility in underserved markets. The acquisition supports Sonic’s strategy to strengthen its footprint in high-demand urban and suburban locations across the U.S.
- In December 2023, Dynacare, a leading diagnostic provider in Canada, launched its Virtual Care Diagnostics Program, offering telehealth-compatible lab testing kits for chronic disease monitoring. This initiative reflects the growing trend of integrating digital health with laboratory diagnostics, aiming to enhance patient engagement and access to timely care in Canada’s evolving healthcare landscape
